London, X0, based Investment company Abingworth LLP (Current Portfolio) buys Soleno Therapeutics Inc, Molecular Templates Inc, sells Proteon Therapeutics Inc during the 3-months ended 2019Q4, according to the most recent filings of the investment company, Abingworth LLP. As of 2019Q4, Abingworth LLP owns 15 stocks with a total value of $169 million. These are the details of the buys and sells.
For the details of Abingworth LLP's stock buys and sells,
go to www.gurufocus.com/guru/abingworth+llp/current-portfolio/portfolio
These are the top 5 holdings of Abingworth LLP
- Personalis Inc (PSNL) - 5,449,294 shares, 34.98% of the total portfolio.
- CRISPR Therapeutics AG (CRSP) - 519,198 shares, 18.66% of the total portfolio. Shares reduced by 17.38%
- Sientra Inc (SIEN) - 2,390,843 shares, 12.58% of the total portfolio.
- Soleno Therapeutics Inc (SLNO) - 6,969,272 shares, 11.76% of the total portfolio. Shares added by 49.26%
- Exicure Inc (XCUR) - 6,977,000 shares, 11.73% of the total portfolio. Shares added by 11.63%
New Purchase: Molecular Templates Inc (MTEM)
Abingworth LLP initiated holding in Molecular Templates Inc. The purchase prices were between $6.44 and $14.21, with an estimated average price of $9.72. The stock is now traded at around $14.50. The impact to a portfolio due to this purchase was 1.65%. The holding were 200,000 shares as of .
Added: Soleno Therapeutics Inc (SLNO)
Abingworth LLP added to a holding in Soleno Therapeutics Inc by 49.26%. The purchase prices were between $1.35 and $2.95, with an estimated average price of $1.72. The stock is now traded at around $2.89. The impact to a portfolio due to this purchase was 3.88%. The holding were 6,969,272 shares as of .
Here is the complete portfolio of Abingworth LLP. Also check out: